JP Morgan Chase’s LifePoint Health, Inc. LPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,375,470
| Closed | -$88.6M | – | 6183 |
|
|
2018
Q3 | $88.6M | Buy |
1,375,470
+958,353
| +230% | +$58.4M | 0.02% | 756 |
|
|
2018
Q2 | $20.4M | Buy |
417,117
+369,357
| +773% | +$19.1M | ﹤0.01% | 1564 |
|
|
2018
Q1 | $2.25M | Sell |
47,760
-1,373
| -3% | -$66.1K | ﹤0.01% | 3195 |
|
|
2017
Q4 | $2.45M | Sell |
49,133
-83,456
| -63% | -$4.15M | ﹤0.01% | 3193 |
|
|
2017
Q3 | $7.76M | Buy |
132,589
+27,726
| +26% | +$1.65M | ﹤0.01% | 2198 |
|
|
2017
Q2 | $7.04M | Buy |
104,863
+3,234
| +3% | +$204K | ﹤0.01% | 2237 |
|
|
2017
Q1 | $6.66M | Buy |
101,629
+21,083
| +26% | +$1.3M | ﹤0.01% | 2231 |
|
|
2016
Q4 | $4.58M | Buy |
80,546
+48,091
| +148% | +$2.78M | ﹤0.01% | 2529 |
|
|
2016
Q3 | $1.92M | Sell |
32,455
-53,571
| -62% | -$3.21M | ﹤0.01% | 2819 |
|
|
2016
Q2 | $5.62M | Sell |
86,026
-37,689
| -30% | -$2.56M | ﹤0.01% | 2210 |
|
|
2016
Q1 | $8.57M | Sell |
123,715
-143,170
| -54% | -$9.56M | ﹤0.01% | 1862 |
|
|
2015
Q4 | $19.6M | Sell |
266,885
-248,130
| -48% | -$17.6M | ﹤0.01% | 1337 |
|
|
2015
Q3 | $36.5M | Sell |
515,015
-5
| -0% | -$406 | 0.01% | 933 |
|
|
2015
Q2 | $44.8M | Sell |
515,020
-246,209
| -32% | -$18.6M | 0.01% | 936 |
|
|
2015
Q1 | $55.9M | Buy |
761,229
+51,788
| +7% | +$3.67M | 0.01% | 841 |
|
|
2014
Q4 | $51M | Buy |
709,441
+631,375
| +809% | +$43.7M | 0.01% | 920 |
|
|
2014
Q3 | $5.4M | Buy |
78,066
+11,785
| +18% | +$829K | ﹤0.01% | 2325 |
|
|
2014
Q2 | $4.12M | Buy |
+66,281
| New | +$3.89M | ﹤0.01% | 2170 |
|
|
2014
Q1 | – | Sell |
-47,117
| Closed | -$2.49M | – | 4249 |
|
|
2013
Q4 | $2.49M | Sell |
47,117
-29,368
| -38% | -$1.47M | ﹤0.01% | 2621 |
|
|
2013
Q3 | $3.57M | Sell |
76,485
-26,749
| -26% | -$1.28M | ﹤0.01% | 2415 |
|
|
2013
Q2 | $5.04M | Buy |
+103,234
| New | +$4.95M | ﹤0.01% | 2127 |
|
Other funds holding LPNT
JP Morgan Chase's LPNT Position: Q4 2018 in Review
JP Morgan Chase sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 1,375,470 shares — an estimated $88.6M sold.
JP Morgan Chase first reported a position in LPNT in Q2 2013 and held it in 21 quarters. The position peaked at $88.6M in Q3 2018. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.
- JP Morgan Chase reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
- JP Morgan Chase sold 1,375,470 LifePoint Health, Inc. shares in Q4 2018, an estimated $88.6M.
- JP Morgan Chase first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 21 quarters.
- JP Morgan Chase's LifePoint Health, Inc. position peaked at $88.6M in Q3 2018.
- 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.
Based on JP Morgan Chase's 13F filing for Q4 2018, filed 11 Feb 2019.